GSK has sometimes behaved extremely unethically in developing countries, therefore everything the Yemeni whistle-blower has told me about GSK’s practices in Yemen really comes as no surprise to me..
DoH §17: Investigations were not ceased after the
risks were found to outweigh the potential benefits.
In 1998, GSK and the Walter Reed Institute, which conducts medical research for the US army, started cooperating to develop a Hepatitis E vaccine. Hepatitis E is a comon disease in poor countries and there have been outbreaks in countries where US troops are deployed. Preparations for phase II trials were made in February 2000. Before launching the trials, GSK had already decided the vaccine would not be commercially developed for a travellers’ market, while Walter Reed decided it would be unsuitable for US soldiers.
Still, GSK and Walter Reed went ahead with phase II trials and wanted to test…
View original post 2,079 more words